Organization attributes
Investor attributes
Other attributes
Bioeconomy Capital is a biotechnology investment firm. The primary focus of Bioeconomy Captial is the industrialization of early stage biotechnology companies operating within the bioeconomy making products such as materials, chemicals, and enzymes.
On January 1, 2017 Bioeconomy Capital completed their bioeconomy fund 1 investment portfolio of early stage biotechnology companies. Bioeconomy Capital invested a total of $8.3 million into 6 early stage biotechnology companies — Zymergen, Riffyn, Rooster Bio, Synthace, Arzeda, and Bellwether Bio.
Bioeconomy Capital is interested in accelerating the strategic analysis of building blueprints and releasing technological capabilities. They look to support synthetic biology and related fields through investments. The company looks to segregate their investments into subsectors including, biologics, crops, and industrial products.
